Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pranay Renukuntla
Observed name:
Renukuntla Pranay
Institutions:
Indian Institute of Chemical Technology,
Academy of Scientific and Innovative Research
Observed institutions:
Indian Institute of Chemical Technology,
Academy of Scientific and Innovative Research
ORCID:
0009-0009-0663-1130
Observed ORCID:
0009-0009-0663-1130
OpenAlex ID:
A5094021180
Formulation, development, and characterization of loratadine emulgel
2024
·
Chandana Setty Sharaff
, Pranay Renukuntla
, et al.
·
Journal of Applied Pharmaceutical Research
·
14
Insights of nose to brain delivery in treating Parkinson’s disease: A systematic review
2024
·
Renukuntla Pranay
, Ravi Kumar Tatikayala
, et al.
·
Journal of Applied Pharmaceutical Research
·
5
PDF
Mass Spectral Studies of N , N ‐Dialkylacetimidamides Using ESI‐HRMS and MS/MS
2025
·
S. Babu Dadinaboyina
, Pranay Renukuntla
, et al.
·
Rapid Communications in Mass Spectrometry
·
4
PDF
Analytical Method Development and Validation of Brivaracetam in API and Marketed Formulation by RP-HPLC
2024
·
Banothu Bhadru
, Peddinti Naveen Kumar
, et al.
·
Asian Journal of Pharmaceutical Research and Development
·
2
PDF
Quality by Design and Characterization of Nimodipine Novel Carriers for the Treatment of Hypertension: Assessment of the Pharmacokinetic Profile
2024
·
Ananda Chettupalli
, Padmanabha Rao Amarachinta
, et al.
·
Current Bioactive Compounds
·
1
Treatment of K562 Cells with ABL Kinase Inhibitors Reveals Differential Metabolic Profiles
2026
·
Pranay Renukuntla
, Sai Charitha Mullaguri
, et al.
·
Drug Research
Correction: Treatment of K562 Cells with ABL Kinase Inhibitors Reveals Differential Metabolic Profiles
2026
·
Pranay Renukuntla
, Sai Charitha Mullaguri
, et al.
·
Drug Research
Show more works
View as search
Works count:
7
Citation count:
26
H-index:
3
I10-index:
1
Year
Topic
Type